Skip to main content

Table 2 Summary of key MicroShunt efficacy outcomes at Years 1–3 [9]

From: Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review

 

Baseline

Year 1

Year 2

Year 3

 Mean medicated IOP, mmHg ± SD

23.8 ± 5.3

10.7 ± 2.8

11.9 ± 3.7

10.7 ± 3.5

 Mean number of glaucoma medications per patient ± SD

2.4 ± 0.9

0.3 ± 0.8

0.4 ± 1.0

0.7 ± 1.1

 Qualified success,a %

–

100

91

95

  1. aQualified success was defined as IOP ≤ 14 mmHg with a ≥ 20% reduction in IOP from baseline, with or without glaucoma medication and with no reoperation for glaucoma
  2. IOP = intraocular pressure; SD = standard deviation
Back to article page

Eye and Vision

ISSN: 2326-0254